205 related articles for article (PubMed ID: 22675471)
1. LSDP5 enhances triglyceride storage in hepatocytes by influencing lipolysis and fatty acid β-oxidation of lipid droplets.
Li H; Song Y; Zhang LJ; Gu Y; Li FF; Pan SY; Jiang LN; Liu F; Ye J; Li Q
PLoS One; 2012; 7(6):e36712. PubMed ID: 22675471
[TBL] [Abstract][Full Text] [Related]
2. LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues.
Dalen KT; Dahl T; Holter E; Arntsen B; Londos C; Sztalryd C; Nebb HI
Biochim Biophys Acta; 2007 Feb; 1771(2):210-27. PubMed ID: 17234449
[TBL] [Abstract][Full Text] [Related]
3. PAT protein mRNA expression in primary rat hepatocytes: Effects of exposure to fatty acids.
Grasselli E; Voci A; Pesce C; Canesi L; Fugassa E; Gallo G; Vergani L
Int J Mol Med; 2010 Apr; 25(4):505-12. PubMed ID: 20198297
[TBL] [Abstract][Full Text] [Related]
4. Lipid storage droplet protein 5 reduces sodium palmitate‑induced lipotoxicity in human normal liver cells by regulating lipid metabolism‑related factors.
Ma X; Cheng F; Yuan K; Jiang K; Zhu T
Mol Med Rep; 2019 Aug; 20(2):879-886. PubMed ID: 31173228
[TBL] [Abstract][Full Text] [Related]
5. OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization.
Wolins NE; Quaynor BK; Skinner JR; Tzekov A; Croce MA; Gropler MC; Varma V; Yao-Borengasser A; Rasouli N; Kern PA; Finck BN; Bickel PE
Diabetes; 2006 Dec; 55(12):3418-28. PubMed ID: 17130488
[TBL] [Abstract][Full Text] [Related]
6. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
Edvardsson U; Ljungberg A; Lindén D; William-Olsson L; Peilot-Sjögren H; Ahnmark A; Oscarsson J
J Lipid Res; 2006 Feb; 47(2):329-40. PubMed ID: 16282640
[TBL] [Abstract][Full Text] [Related]
7. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Pant A; Rondini EA; Kocarek TA
Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids regulate perilipin5 in muscle by activating PPARδ.
Bindesbøll C; Berg O; Arntsen B; Nebb HI; Dalen KT
J Lipid Res; 2013 Jul; 54(7):1949-63. PubMed ID: 23606724
[TBL] [Abstract][Full Text] [Related]
9. S3-12, Adipophilin, and TIP47 package lipid in adipocytes.
Wolins NE; Quaynor BK; Skinner JR; Schoenfish MJ; Tzekov A; Bickel PE
J Biol Chem; 2005 May; 280(19):19146-55. PubMed ID: 15731108
[TBL] [Abstract][Full Text] [Related]
10. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
[TBL] [Abstract][Full Text] [Related]
11. ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle.
Meex RC; Hoy AJ; Mason RM; Martin SD; McGee SL; Bruce CR; Watt MJ
Am J Physiol Endocrinol Metab; 2015 Jun; 308(11):E960-70. PubMed ID: 25852007
[TBL] [Abstract][Full Text] [Related]
12. Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver.
Zhu YX; Zhang ML; Zhong Y; Wang C; Jia WP
J Diabetes Res; 2016; 2016():8315454. PubMed ID: 26770990
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes.
de la Rosa Rodriguez MA; Deng L; Gemmink A; van Weeghel M; Aoun ML; Warnecke C; Singh R; Borst JW; Kersten S
Mol Metab; 2021 May; 47():101168. PubMed ID: 33465519
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion.
Mattijssen F; Georgiadi A; Andasarie T; Szalowska E; Zota A; Krones-Herzig A; Heier C; Ratman D; De Bosscher K; Qi L; Zechner R; Herzig S; Kersten S
J Biol Chem; 2014 Jul; 289(28):19279-93. PubMed ID: 24876382
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin reduces lipid accumulation in the liver by activating protein kinase A-mediated phosphorylation of perilipin 5.
Gao X; Nan Y; Zhao Y; Yuan Y; Ren B; Sun C; Cao K; Yu M; Feng X; Ye J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Dec; 1862(12):1512-1519. PubMed ID: 28919478
[TBL] [Abstract][Full Text] [Related]
16. Nuclear Perilipin 5 integrates lipid droplet lipolysis with PGC-1α/SIRT1-dependent transcriptional regulation of mitochondrial function.
Gallardo-Montejano VI; Saxena G; Kusminski CM; Yang C; McAfee JL; Hahner L; Hoch K; Dubinsky W; Narkar VA; Bickel PE
Nat Commun; 2016 Aug; 7():12723. PubMed ID: 27554864
[TBL] [Abstract][Full Text] [Related]
17. Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis.
Wang C; Zhao Y; Gao X; Li L; Yuan Y; Liu F; Zhang L; Wu J; Hu P; Zhang X; Gu Y; Xu Y; Wang Z; Li Z; Zhang H; Ye J
Hepatology; 2015 Mar; 61(3):870-82. PubMed ID: 25179419
[TBL] [Abstract][Full Text] [Related]
18. Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes.
Kim MS; Lee KT; Iseli TJ; Hoy AJ; George J; Grewal T; Roufogalis BD
Liver Int; 2013 Nov; 33(10):1583-93. PubMed ID: 23998390
[TBL] [Abstract][Full Text] [Related]
19. [Construction of eukaryotic fusion expression vectors of LSDP5 and cellular localization].
Liu F; Zhang LJ; Ye J; Zhang LY; Li FF; Li H; Gu Y; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):438-9. PubMed ID: 20423650
[TBL] [Abstract][Full Text] [Related]
20. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
